Prostate Cancer

Lead Researcher:

Dr Paul Cozzi

Significance

Most significant advances or findings in past 10yrs

Research interests include experimental therapeutics for Ca prostate in the lab and clinic and newer markers for diagnosis.

Recent publications

Cozzi PJ, Wang J, Delprado W, Madigan MC, Russell PJ, Li Y. Evaluation of urokinase plasminogen activator (uPA) and its receptor (uPAR) in different grades of prostate cancer. Human Pathol 2006;37:1442-5.

Yong Li, Syed M. Abbas Rizvi Julie M. Blair (nee Brown), Paul J. Cozzi, Chang F. Qu, Kim T. Ow, Patrick N. Tam, Alan C. Perkins, Pamela J. Russell and Barry J. Allen. Antigenic expression of human metastatic prostate cancer cell lines for in vitro multiple-targeted Éø-therapy with 213Bi-conjugates. International Journal of Radiation Oncology, Biology, Physics Volume 60, (3), 2004, 896-908

Cozzi, P Malhotra S, Kooby, D; McAuliffe, P; Federoff, H; Huryk, B; Johnson P, Scardino PT, Heston, W ; Fong Y, Y. Intravesical oncolytic viral therapy using attenuated, replication-competent herpes simplex viruses G207 and Nv1020 is effective in the treatment of bladder cancer in an orthotopic syngeneic model. FASEB Journal 15(7):1306-8, 2001